Raymond James Financial Inc Omeros Corp Transaction History
Raymond James Financial Inc
- $299 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding OMER
# of Institutions
155Shares Held
33.1MCall Options Held
2.2MPut Options Held
2.72M-
Ingalls & Snyder LLC New York, NY4.11MShares$30.4 Million0.55% of portfolio
-
Black Rock Inc. New York, NY4.1MShares$30.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.35MShares$24.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.99MShares$14.7 Million0.0% of portfolio
-
Stifel Financial Corp St. Louis, MO1.81MShares$13.4 Million0.01% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $465M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...